PLoS ONE · 2011 · 90 citations · 29 references
MedicineOncologyPharmacologyCell SignalingMolecular OncologyStem Cell BiologyCancer Cell SignalingCancer Stem Cell BiologyCancer Stem Cell MaintenanceCancer Stem CellsHormonal TherapyProstate CancerCancer Stem Cell Signaling PathwaysCancer Stem Cell TargetingCancer Stem Cell TraitsCancer Stem-like CellsProstate Stem Cell BiologyStat3 Signaling
Galiellalactone is a potent and specific inhibitor of STAT3 signaling which has been shown to possess growth inhibitory effects on prostate cancer cells expressing active STAT3. In this study we aimed to investigate the effect of galiellalactone on prostate cancer stem cell-like cells. We explored the expression of aldehyde dehydrogenase (ALDH) as a marker for cancer stem cell-like cells in different human prostate cancer cell lines and the effects of galiellalactone on ALDH expressing (ALDH+) prostate cancer cells. ALDH+ subpopulations were detected and isolated from the human prostate cancer cell lines DU145 and long-term IL-6 stimulated LNCaP cells using ALDEFLUOR® assay and flow cytometry. In contrast to ALDH- cells, ALDH+ prostate cancer cells showed cancer stem cell-like characteristics such as increased self-renewing and colony forming capacity and tumorigenicity. In addition, ALDH+ cells showed an increased expression of putative prostate cancer stem cell markers (CD44 and integrin α2β1). Furthermore, ALDH+ cells expressed phosphorylated STAT3. Galiellalactone treatment decreased the proportion of ALDH+ prostate cancer cells and induced apoptosis of ALDH+ cells. The gene expression of ALDH1A1 was downregulated in vivo in galiellalactone treated DU145 xenografts. These findings emphasize that targeting the STAT3 pathway in prostate cancer cells, including prostate cancer stem cell-like cells, is a promising therapeutic approach and that galiellalactone is an interesting compound for the development of future prostate cancer drugs.
29
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2009 · 9.7K citations · Full text
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells
Anne T. Collins, Paul A. Berry, Catherine Hyde et al. · Cancer Research · 2005 · 2.8K citations
Medicine, Cell Biology, Oncology +17
Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
Feng Jiang, Qi Qiu, Abha Khanna et al. · Molecular Cancer Research · 2009 · 797 citations · Full text
Medicine, Cell Biology, Oncology +17